Can artificial intelligence overcome the challenges of the health care system?
MIT and Mass General Brigham researchers and physicians connect in person to bring AI into mainstream health care.
Tracing a cancer’s family tree to its roots reveals how tumors grow
Family trees of lung cancer cells reveal how cancer evolves from its earliest stages to an aggressive form capable of spreading throughout the body.
Advocating for vaccine equity
Postdoc Digbijay Mahat became a cancer researcher to improve health care in Nepal, but the Covid-19 pandemic exposed additional resource disparities.
Bridging the worlds of research and industry
PhD student Nidhi Juthani has built a deep foundation in science to inform a career in the private sector.
Mentorship and medicine
MIT senior Daniel Zhang aims to provide hope for young patients and support to young students.
Probing how proteins pair up inside cells
MIT biologists drilled down into how proteins recognize and bind to one another, informing drug treatments for cancer.
Seeing into the future: Personalized cancer screening with artificial intelligence
Scientists demonstrate that AI-risk models, paired with AI-designed screening policies, can offer significant and equitable improvements to cancer screening.
Method for delivering immune system-stimulating drugs may enhance cancer immunotherapy
The targeted approach eliminated tumors in mice, with minimal side effects.
3 Questions: Kristin Knouse on the liver’s regenerative capabilities
The clinically-trained cell biologist exploits the liver’s unique capacities in search of new medical applications.
Measuring cancer cell state can reveal drug susceptibility
Study results also show that pancreatic tumor cells can be forced into a more susceptible state by changing their environment.
A stealthy way to combat tumors
MIT biologists show that helper immune cells disguised as cancer cells can help rejuvenate T cells that attack tumors.
Modeling the mechanisms of metastasis
Collaborative team wins prestigious NIH grant to investigate the physical forces that influence metastatic cancer.
Hunting a “Jekyll-and-Hyde” molecule
A screening method developed by MIT researchers targets hydrogen peroxide in the search for new cancer therapeutics.
Diagnosing cancer with a barcode-inspired test
Dana Al-Sulaiman, a recent postdoc with MIT’s Ibn Khaldun Fellowship for Saudi Arabian Women, has developed a cheap, minimally invasive diagnostic test for cancer.
Differences in T cells’ functional states determine resistance to cancer therapy
Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.